4.3 Article

Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease

Journal

NUCLEAR MEDICINE AND BIOLOGY
Volume 38, Issue 3, Pages 313-320

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.nucmedbio.2010.09.012

Keywords

Alzheimer's disease; beta-Amyloid; Single photon emission computed tomography (SPECT); Imaging agent

Funding

  1. Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)
  2. Ministry of Education, Culture, Sports, Science and Technology, Japan
  3. China Scholarship Council (CSC)

Ask authors/readers for more resources

Five iodinated 2-phenyl- l H-benzo[d]imidazole derivatives were synthesized and evaluated as potential probes for beta-amyloid (A beta) plaques. One of the compounds, 4-(6-iodo- l H-benzo[d]imidazol-2-yl)-N,N-dimethylaniline (12), showed excellent affinity for A beta(1-42) aggregates (K-i=9.8 nM). Autoradiography with sections of postmortem Alzheimer's disease (AD) brain revealed that a radioiodinated probe [I-125]12, labeled A beta plaques selectively with low nonspecific binding. Biodistribution experiments with normal mice injected intravenously with [I-125]12 showed high uptake [4.14 percent injected close per gram (% ID/g) at 2 min] into and rapid clearance (0.15% lD/g at 60 min) from the brain, which may bring about a good signal-to-noise ratio and therefore achieve highly sensitive detection of A beta plaques. In addition, [I-125]12 labeled amyloid plaques in vivo in an AD transgenic model. The preliminary results strongly suggest that [I-125]12 bears characteristics suitable for detecting amyloid plaques in vivo. When labeled with I-123, it may be a useful SPECT imaging agent for A beta plaques in the brain of living AD patients. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

18F-labeled 2-phenylbenzoheterocycles with chiral dihydroxyl side chains as β-amyloid imaging probes

Yuying Li, Kaixiang Zhou, Wentao Guo, Mengchao Cui

Summary: This study focused on designing 2-phenylbenzoheterocycles with chiral dihydroxyl side chains as beta-amyloid imaging probes, which exhibited good binding affinities and improved brain kinetics compared to existing derivatives. The (S, R)-[F-18]14 probe showed high affinity and specificity to A beta plaques, making it a promising potential PET imaging probe for early diagnosis of Alzheimer's disease.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Chemistry, Physical

Near-Infrared Fluorescent Probes with Rotatable Polyacetylene Chains for the Detection of Amyloid-β Plaques

Longfei Zhang, Xin Gong, Chuan Tian, Hualong Fu, Hongwei Tan, Jiapei Dai, Mengchao Cui

Summary: This study designed a new series of near-infrared probes with different numbers of conjugated triple bonds for efficient detection of A beta plaques.

JOURNAL OF PHYSICAL CHEMISTRY B (2021)

Article Medicine, Research & Experimental

Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents

Kaixiang Zhou, Fan Yang, Yuying Li, Yimin Chen, Xiaojun Zhang, Jinming Zhang, Junfeng Wang, Jiapei Dai, Lisheng Cai, Mengchao Cui

Summary: This study evaluated three pairs of optically pure F-18-labeled 2-phenylquinoxaline derivatives as potential Tau imaging agents for AD diagnosis, showing high selectivity and affinity for Tau tangles over A beta. The PET probes (R)-[F-18]5 and (S)-[F-18]16 demonstrated promising brain penetration, kinetics, and stability, making them suitable candidates for Tau tangle imaging.

MOLECULAR PHARMACEUTICS (2021)

Article Chemistry, Medicinal

Synthesis, Preclinical Evaluation, and First-in-Human PET Study of Quinoline-Containing PSMA Tracers with Decreased Renal Excretion

Xiaojun Zhang, Yitian Wu, Qi Zeng, Tianxin Xie, Shulin Yao, Jinming Zhang, Mengchao Cui

Summary: The study designed, synthesized, and evaluated three more lipophilic F-18-labeled PSMA tracers, investigating the effect of lipophilicity on their distribution and excretion in different species. Higher lipophilicity led to increased radioactivity accumulation in the liver of primates and humans, as well as reduced excretion to the bladder through urine. The screened tracer [F-18]8c showed low bladder retention and good imaging properties in patients with prostate cancer.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection

Longfei Zhang, Xiaojing Shi, Yuying Li, Xiaojiang Duan, Zeyu Zhang, Hualong Fu, Xing Yang, Jie Tian, Zhenhua Hu, Mengchao Cui

Summary: A novel probe PSMA-1092 with high affinity for PSMA was developed for precise tumor resection in radical prostatectomy, showing excellent performance in delineating tumor margin and detecting residual tumors in real-time NIR-II imaging, offering promising potential for clinical practice.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Pharmacology & Pharmacy

Discovery and development of brain-penetrant 18F-labeled radioligands for neuroimaging of the sigma-2 receptors

Ying Zhang, Tao Wang, Xiaojun Zhang, Winnie Deuther-Conrad, Hualong Fu, Mengchao Cui, Jinming Zhang, Peter Brust, Yiyun Huang, Hongmei Jia

Summary: In this study, a series of indole-based derivatives were synthesized as novel sigma-2 receptor ligands, and two ligands with high affinity and selectivity were radiolabeled with F-18. Biodistribution studies in rodents showed that the radioligand [F-18]9 displayed high brain uptake and brain-to-blood ratio. Pre-treatment experiments and ex vivo autoradiography confirmed the specific binding of [F-18]9 to sigma-2 receptors in the brain. Dynamic positron emission tomography imaging further confirmed the regional distribution and specific binding of [F-18]9 in the rat brain.

ACTA PHARMACEUTICA SINICA B (2022)

Article Biotechnology & Applied Microbiology

68Ga-DOTA-DiPSMA PET/CT Imaging: Biodistribution, Dosimetry, and Preliminary Application in Prostate Cancer

Jiaying Zhang, Zefang Lin, Xiaojun Zhang, Rong Lin, Mengchao Cui, Weibing Miao, Shaobo Yao

Summary: The injection of Ga-68-DOTA-DiPSMA is safe and associated with low absorbed and effective doses. Ga-68-DOTA-DiPSMA demonstrates favorable kinetics and imaging characteristics, showing potential as an alternative for gallium-68-labeled PSMA clinical PET.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Biotechnology & Applied Microbiology

Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer's Disease

Ying Wang, Li Cai, Kaixiang Zhou, Mengchao Cui, Shaobo Yao

Summary: This study reported a fully automated radiosynthetic procedure of a novel tau tracer [F-18]-S16 and evaluated its safety, biodistribution, and dosimetry in healthy volunteers as well as its potential utility in Alzheimer's disease (AD). The results showed that [F-18]-S16 could be synthesized automatically with favorable biodistribution and safety in humans. [F-18]-S16 PET demonstrated high image quality for imaging tau deposition in AD and distinguishing AD from healthy controls.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)

Article Geriatrics & Gerontology

Genetic and Molecular Evaluation of SQSTM1/p62 on the Neuropathologies of Alzheimer's Disease

Wei Dong, Meng-Chao Cui, Wen-Zheng Hu, Qi Zeng, Yi-Long Wang, Wei Zhang, Yue Huang

Summary: SQSTM1/p62 plays an important role in the progression of Alzheimer's disease (AD) through its associations with A beta(42) levels in cerebrospinal fluid (CSF) and A beta deposition in the brain of AD patients, as revealed by genetic associations and immunoreactivity analysis.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Chemistry, Multidisciplinary

Recent development in selective Tau tracers for PET imaging in the brain

Yuying Li, Tianqing Liu, Mengchao Cui

Summary: This review summarizes the latest development of Tau tracers and analyzes their chemical structures and biological properties. The limitations of current tracers and considerations for the development of new tracers are also discussed.

CHINESE CHEMICAL LETTERS (2022)

Article Chemistry, Analytical

D-π-A-Based Trisubstituted Alkenes as Environmentally Sensitive Fluorescent Probes to Detect Lewy Pathologies

Qi Zeng, Yimin Chen, Yingying Yan, Rong Wan, Yanjing Li, Hualong Fu, Yu Liu, Sen Liu, Xiao-Xin Yan, Mengchao Cui

Summary: By rational design, a series of D-pi-A-based trisubstituted alkenes were developed, which showed high binding affinities to alpha-syn fibrils and promising potential for the in vitro neuropathological staining of Lewy pathologies.

ANALYTICAL CHEMISTRY (2022)

Article Geriatrics & Gerontology

In vivo imaging of tau deposition in Alzheimer's disease using both [18F]-THK5317 and [18F]-S16: A pilot human study

Liping Fu, Jinming Zhang, Kaixiang Zhou, Xiaojun Zhang, Hengge Xie, Mingwei Zhu, Mengchao Cui, Ruimin Wang

Summary: This study evaluates the effectiveness of a new tracer, [F-18]-S16, in distinguishing patients with AD from HCs. The results show that [F-18]-S16 exhibits increased cortical uptake in AD patients, suggesting its potential for in vivo detection of tau protein.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Chemistry, Medicinal

Fused Cycloheptatriene-BODIPY Is a High-Performance Near-Infrared Probe to Image Tau Tangles

Tianxin Xie, Yuying Li, Chuan Tian, Chang Yuan, Bin Dai, Shubo Wang, Kaixiang Zhou, Jiaqi Liu, Hongwei Tan, Yi Liang, Jiapei Dai, Baian Chen, Mengchao Cui

Summary: This study developed a novel probe TNIR7-1A that can selectively detect NFTs and clearly distinguish tauopathy from the control group in vivo.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Fluorine-18-Labeled Diaryl-azines as Improved ?-Amyloid Imaging Tracers: From Bench to First-in-Human Studies

Yuying Li, Kaixiang Zhou, Xiaojun Zhang, Hailong Zhao, Xiaoming Wang, Ruilin Dong, Yan Wang, Baian Chen, Xiao-xin Yan, Jiapei Dai, Yanying Sui, Jinming Zhang, Mengchao Cui

Summary: We have discovered and developed a class of diaryl-azine derivatives for detecting Afi plaques in the AD brain using PET imaging. After comprehensive assessments, we identified a promising Afi-PET tracer, [18F]92, with high binding affinity to Afi aggregates, significant binding ability with AD brain sections, and optimal brain pharmacokinetic properties. The first in-human PET study showed that [18F]92 displayed low white matter uptake and could bind to Afi pathology for distinguishing AD from healthy controls, making it a promising PET tracer for visualizing Afi pathology in AD patients.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Design and synthesis of a new conjugate of a tris(3-hydroxy-4-pyridinone) chelator (KC18) for potential use as gallium-68-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical

Xu Zhou, Lin-Lin Dong, Yuying Li, Meng-Chao Cui, Lang-Tao Shen

Summary: Prostate-specific membrane antigen (PSMA) is a significant target for prostate cancer diagnosis and therapy. The combination of DUPA with a multidentate bifunctional chelator successfully targets PSMA and forms a new precursor for gallium-68 radiopharmaceutical, DUPA beta-Ala-KC18. This novel compound displays binding affinity to PSMA.

RESULTS IN CHEMISTRY (2021)

No Data Available